Nurse-Provided Medication Guidance for Improving Drug Adherence to Thiopurines in Outpatients With Inflammatory Bowel Disease: A Single-Center Prospective Study.

drug adherence multidisciplinary team nurse-provided medication guidance thiopurine

Journal

Crohn's & colitis 360
ISSN: 2631-827X
Titre abrégé: Crohns Colitis 360
Pays: England
ID NLM: 101752188

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 14 09 2021
entrez: 13 2 2023
pubmed: 16 12 2021
medline: 16 12 2021
Statut: epublish

Résumé

Drug adherence is critically important for patients on thiopurines. We examined whether nurse-provided medication guidance improves drug adherence to thiopurines and clinical activity in patients with inflammatory bowel disease (IBD). IBD outpatients taking a stable dose of thiopurines for 1 year were enrolled. After a baseline survey including the Morisky Medication Adherence Scale (MMAS)-8, nurses provided medication guidance to each patient using a specialized leaflet. The same survey was conducted 2 and 6 months after the guidance. Among 110 enrolled patients, 74 met the analysis criteria. In the low adherence group (MMAS-8 <6), the median MMAS-8 score significantly increased from 4 (range 1-5.75) to 5.25 (2-7) at 2 months ( Nurse-provided medication guidance improved drug adherence to thiopurines in IBD patients with low adherence and can also benefit those with high adherence.

Sections du résumé

Background and Aims UNASSIGNED
Drug adherence is critically important for patients on thiopurines. We examined whether nurse-provided medication guidance improves drug adherence to thiopurines and clinical activity in patients with inflammatory bowel disease (IBD).
Methods UNASSIGNED
IBD outpatients taking a stable dose of thiopurines for 1 year were enrolled. After a baseline survey including the Morisky Medication Adherence Scale (MMAS)-8, nurses provided medication guidance to each patient using a specialized leaflet. The same survey was conducted 2 and 6 months after the guidance.
Results UNASSIGNED
Among 110 enrolled patients, 74 met the analysis criteria. In the low adherence group (MMAS-8 <6), the median MMAS-8 score significantly increased from 4 (range 1-5.75) to 5.25 (2-7) at 2 months (
Conclusions UNASSIGNED
Nurse-provided medication guidance improved drug adherence to thiopurines in IBD patients with low adherence and can also benefit those with high adherence.

Identifiants

pubmed: 36777553
doi: 10.1093/crocol/otab081
pii: otab081
pmc: PMC9802065
doi:

Types de publication

Journal Article

Langues

eng

Pagination

otab081

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of Crohn's & Colitis Foundation.

Références

Gut. 2006 Jun;55(6):749-53
pubmed: 16698746
J Crohns Colitis. 2017 Oct 27;11(11):1302-1308
pubmed: 28981622
N Engl J Med. 2010 Apr 15;362(15):1383-95
pubmed: 20393175
Gastroenterology. 1976 Mar;70(3):439-44
pubmed: 1248701
Aliment Pharmacol Ther. 2013 Nov;38(9):1097-108
pubmed: 24099471
Inflamm Bowel Dis. 2013 Feb;19(2):321-31
pubmed: 23287897
World J Gastroenterol. 2011 Oct 7;17(37):4166-73
pubmed: 22072847
Inflamm Bowel Dis. 2019 Jan 1;25(1):142-149
pubmed: 29920603
J Clin Invest. 2003 Jun;111(12):1805-12
pubmed: 12813013
Gut. 2019 Dec;68(Suppl 3):s1-s106
pubmed: 31562236
Chemphyschem. 2007 Mar 12;8(4):507-9
pubmed: 17286323
N Engl J Med. 1987 Dec 24;317(26):1625-9
pubmed: 3317057
Gut. 2004 Nov;53(11):1639-45
pubmed: 15479685
Inflamm Bowel Dis. 2003 Jul;9(4):237-45
pubmed: 12902847
Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1313-9
pubmed: 27501126
Gastroenterology. 2014 Feb;146(2):392-400.e3
pubmed: 24512909
Am J Gastroenterol. 2010 Mar;105(3):525-39
pubmed: 19997092
J Gastroenterol. 2021 Jun;56(6):489-526
pubmed: 33885977
J Clin Hypertens (Greenwich). 2008 May;10(5):348-54
pubmed: 18453793
J Gastroenterol. 2021 Jun;56(6):560-569
pubmed: 33942166
PLoS One. 2017 Nov 2;12(11):e0187139
pubmed: 29095870
Gastroenterology. 2021 Apr;160(5):1570-1583
pubmed: 33359090

Auteurs

Shinichiro Shinzaki (S)

Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan.

Kayoko Sakagami (K)

Kinshukai Infusion Clinic, Osaka, Japan.

Miki Matsumoto (M)

Kinshukai Infusion Clinic, Osaka, Japan.

Tetsuo Takehara (T)

Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Osaka, Japan.

Hiroaki Ito (H)

Kinshukai Infusion Clinic, Osaka, Japan.

Classifications MeSH